Month: April 2022

April 15, 2022 Conditions of availability of information preparedin connection with the Extraordinary Shareholders’ Meetingto be held May 6, 2022 Shareholders are invited to participate to the Ordinary and Extraordinary Shareholders’ Meeting to be held on: Friday May 6, 2022 at 12:00 pm,Espace Saint-Martin – 199 bis rue Saint-Martin – 75003 Paris (France) The Preliminary Notice of Meeting worth Notice of Meeting (avis préalable de réunion valant avis de convocation), including agenda and proposed resolutions was published in the French Bulletin des annonces légales obligatoires (BALO) on April 1st, 2022. The documents referred to in article R. 225-83 of the French Commercial Code are made available to shareholders as of this date, in accordance with applicable regulations:any shareholder holding registered shares may request that the...

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“Affinor” or the “Company”) (CSE: AFI; OTCQB: RSSFF) is pleased to announce that it has shipped its first harvest of vertically grown, vine ripened, cultivar strawberries to Four Seasons Farm at the global tourist attraction, Granville Island Public Market. The premium, sustainable, greenhouse strawberries are being sold as an Abbotsford local product through distributor, Berrymobile. The strawberry harvest, packaging and delivery to local markets represents a successful commercial pilot of Affinor’s patented rotating towers (Canada, USA, Colombia, and Aruba), automated systems and processes. The berries were grown in Affinor’s 15,000 square foot greenhouse in Abbotsford BC from seedlings over the winter of 2022. Affinor is in the process of permitting...

BURLINGTON, Mass., April 15, 2022 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 8054167. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable...

Peapack Capital Peapack CapitalBedminster, NJ, April 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) proudly celebrates the 5th anniversary of the launch of its equipment leasing and financing arm, Peapack Capital.  Over the past five years, Peapack Capital, a Peapack-Gladstone Bank subsidiary founded in April of 2017, has originated over $1.3 billion in new business and has grown its team from six to sixteen.  2021 was a record year for new business originations and the leasing portfolio totaled more than $775 million at year-end. “Peapack Capital has consistently achieved its new business goals and has created a strong and diversified portfolio that has performed very well despite a challenging environment,” said Greg Smith, Senior Executive Vice...

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that further to its acquisition of Praesidio Health Inc. as a natural health medicine division, the Company has elected to expand its leadership team effective immediately. As Isracann moves from development to operations, and to better accommodate the integration of natural health medicine (“NHM”) research and development to meet its near-term commercial goals for revenue generation this year, the Company wishes to introduce added expertise and, in some instances, refocus the efforts of veteran team members into a new more efficiently focused Isracann leadership team for the remainder of 2022 and beyond. Mr. James (JT) Thompson joins as Chief Operations OfficerMr....

NORTH BILLERICA, Mass., April 15, 2022 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Friday, April 29, 2022, to discuss its financial and operating results for the first quarter of 2022. To access the live conference call via telephone, please dial 1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers) and provide passcode 8691334. A live webcast will also be available in the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available in the Investors section of the Company’s website approximately two hours after completion of the call and will be archived for 30 days. About Lantheus Holdings, Inc. Lantheus Holdings, Inc. is the parent company of Lantheus...

Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday, April 18, 2022 at 8:30 AM ET NEW YORK, April 15, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that the Company has voluntarily withdrawn the pending Biologics License Application (BLA)/supplemental New Drug Application (sNDA) for the combination of ublituximab and UKONIQ® (umbralisib) (combination referred to as U2) for the treatment of adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). The decision to withdraw was based on recently updated overall survival (OS) data from the UNITY-CLL Phase 3 trial that showed an increasing imbalance in OS. Additional details are included below in the section entitled “ABOUT...

Net proceeds to be used to strengthen balance sheet for first year as a “pure-play” converged communications company ATLANTA, April 15, 2022 (GLOBE NEWSWIRE) — American Virtual Cloud Technologies, Inc. (Nasdaq: AVCT) (the “Company”) today announced that it has entered into a securities purchase agreement for the sale of a new series of senior secured convertible notes (the “Notes”) to an institutional investor, subject to customary closing conditions. The proceeds, after original issue discount, will total $10 million, before payment of commissions and expenses. Provided no Event of Default (as defined in the Notes) has occurred, the Notes will not accrue interest, and the Company will be required to redeem $800,000 of the outstanding amounts under the Notes each month commencing August 1, 2022, until the maturity date of October...